DAFNA Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-341,779
| Closed | -$858K | – | 75 |
|
|
2020
Q3 | $858K | Sell |
341,779
-420,887
| -55% | -$1.06M | 0.28% | 58 |
|
|
2020
Q2 | $10.4M | Sell |
762,666
-90,872
| -11% | -$1.23M | 2.99% | 6 |
|
|
2020
Q1 | $6.47M | Buy |
853,538
+83,000
| +11% | +$629K | 2.7% | 11 |
|
|
2019
Q4 | $4.87M | Sell |
770,538
-57,500
| -7% | -$363K | 1.67% | 15 |
|
|
2019
Q3 | $3.25M | Sell |
828,038
-2,500
| -0.3% | -$9.8K | 1.22% | 25 |
|
|
2019
Q2 | $4.02M | Buy |
830,538
+115,000
| +16% | +$557K | 1.51% | 20 |
|
|
2019
Q1 | $5.86M | Hold |
715,538
| – | – | 2.53% | 10 |
|
|
2018
Q4 | $3.96M | Buy |
715,538
+89,800
| +14% | +$497K | 1.97% | 15 |
|
|
2018
Q3 | $5.53M | Buy |
625,738
+15,000
| +2% | +$132K | 2.27% | 10 |
|
|
2018
Q2 | $6.1M | Hold |
610,738
| – | – | 2.85% | 8 |
|
|
2018
Q1 | $5.82M | Buy |
610,738
+475,000
| +350% | +$4.53M | 2.83% | 8 |
|
|
2017
Q4 | $2.02M | Hold |
135,738
| – | – | 1.09% | 31 |
|
|
2017
Q3 | $2.67M | Hold |
135,738
| – | – | 1.66% | 20 |
|
|
2017
Q2 | $1.95M | Buy |
135,738
+65,283
| +93% | +$938K | 1.39% | 25 |
|
|
2017
Q1 | $648K | Buy |
+70,455
| New | +$648K | 0.55% | 51 |
|
|
2016
Q3 | – | Sell |
-24,700
| Closed | -$185K | – | 80 |
|
|
2016
Q2 | $185K | Sell |
24,700
-41,000
| -62% | -$307K | 0.15% | 80 |
|
|
2016
Q1 | $592K | Buy |
+65,700
| New | +$592K | 0.51% | 57 |
|